Correlation analysis of mesenchymal-epithelial transition factor protein and human epidermal growth receptor 2 protein expression in 1479 cases of lung adenocarcinoma in China.

about

Correlation analysis of mesenchymal-epithelial transition factor protein and human epidermal growth receptor 2 protein expression in 1479 cases of lung adenocarcinoma in China.

Item

http://www.wikidata.org/entity/Q48107341

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Correlation analysis of mesenc ...... lung adenocarcinoma in China.

@en

Correlation analysis of mesenc ...... lung adenocarcinoma in China.

@nl

type

Item

label

Correlation analysis of mesenc ...... lung adenocarcinoma in China.

@en

Correlation analysis of mesenc ...... lung adenocarcinoma in China.

@nl

prefLabel

Correlation analysis of mesenc ...... lung adenocarcinoma in China.

@en

Correlation analysis of mesenc ...... lung adenocarcinoma in China.

@nl

P1476

Correlation analysis of mesenc ...... lung adenocarcinoma in China.

@en

P2093

Bingning Wang

http://www.w3.org/2001/XMLSchema#string

Bo Zheng

http://www.w3.org/2001/XMLSchema#string

Junling Li

http://www.w3.org/2001/XMLSchema#string

Lei Guo

http://www.w3.org/2001/XMLSchema#string

Yiqun Che

http://www.w3.org/2001/XMLSchema#string

Zhenxi Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms

Crizotinib resistance: implications for therapeutic strategies

A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers

STRING v10: protein-protein interaction networks, integrated over the tree of life

EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.

Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells.

Detection of ALK translocation in non-small cell lung carcinoma (NSCLC) and its clinicopathological significance using the Ventana immunohistochemical staining method: a single-center large-scale investigation of 1, 504 Chinese Han patients.

Targeting HER2 in the treatment of non-small cell lung cancer.

Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancer.

Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas.

P304

439-444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1759-7714.12595

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yixiang Zhu

Lin Yang

P577

2018-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29400000

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

5879060

http://www.w3.org/2001/XMLSchema#string